07-AUG-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 860 16 835 89 1084 182 1108
ERLYTX 82 0 0 8 97 14 85
GI 206 2 104 12 146 32 195
GU 486 1 52 31 377 76 463
LEUK 112 4 209 11 134 26 158
LUNG 398 3 157 18 219 27 164
LYMPH 333 5 261 29 353 56 341
MELAN 425 6 313 46 560 79 481
MMYEL 252 2 104 11 134 20 122
MULT 5 0 0 0 0 2 12
OTHER 29 0 0 3 37 7 43
PREV 6 0 0 0 0 0 0
SXQOL 5 0 0 0 0 1 6
Total 3199 39 2035 258 3141 522 3178

07-AUG-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 324 1 52 7 85 17 103
ERLYTX 8 1 52 1 12 2 12
GU 1 0 0 0 0 0 0
LEUK 607 16 835 52 633 105 639
LUNG 252 2 104 29 353 49 298
OTHER 23 3 157 4 49 4 24
PEOLC 58 2 104 13 158 19 116
PREV 299 5 261 19 231 28 170
SXQOL 621 6 313 38 463 82 499
Total 2193 36 1878 163 1984 306 1861

07-AUG-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 860 16 835 89 1084 182 1108
CCD 324 1 52 7 85 17 103
ERLYTX 90 1 52 9 110 16 97
GI 206 2 104 12 146 32 195
GU 487 1 52 31 377 76 463
LEUK 719 20 1044 63 767 131 797
LUNG 650 5 261 47 572 76 463
LYMPH 333 5 261 29 353 56 341
MELAN 425 6 313 46 560 79 481
MMYEL 252 2 104 11 134 20 122
MULT 5 0 0 0 0 2 12
OTHER 52 3 157 7 85 11 67
PEOLC 58 2 104 13 158 19 116
PREV 305 5 261 19 231 28 170
SXQOL 626 6 313 38 463 83 505
Total 5392 75 3913 421 5125 828 5040

07-AUG-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 520 8 417 53 645 112 682
ERLYTX 45 0 0 1 12 6 37
GI 154 2 104 8 97 19 116
GU 425 0 0 26 317 65 396
LEUK 73 3 157 9 110 20 122
LUNG 242 1 52 13 158 19 116
LYMPH 219 3 157 19 231 36 219
MELAN 257 3 157 32 390 53 323
MMYEL 161 2 104 10 122 14 85
MULT 3 0 0 0 0 1 6
OTHER 29 0 0 3 37 7 43
PREV 6 0 0 0 0 0 0
SXQOL 5 0 0 0 0 1 6
Total 2139 22 1148 174 2119 353 2151

07-AUG-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 266 1 52 7 85 16 97
ERLYTX 7 0 0 0 0 1 6
GU 1 0 0 0 0 0 0
LEUK 270 8 417 26 317 51 310
LUNG 143 1 52 20 244 35 213
OTHER 22 2 104 3 37 3 18
PEOLC 38 1 52 9 110 12 73
PREV 298 4 209 18 219 27 164
SXQOL 417 4 209 23 280 49 298
Total 1462 21 1095 106 1292 194 1179

07-AUG-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 702 11 574 70 852 141 858
CCD 301 1 52 7 85 19 116
ERLYTX 52 0 0 1 12 7 43
GI 157 2 104 7 85 19 116
GU 438 1 52 28 341 67 408
LEUK 343 11 574 35 426 71 432
LUNG 386 2 104 33 402 54 329
LYMPH 219 3 157 19 231 36 219
MELAN 257 3 157 32 390 53 323
MMYEL 159 2 104 10 122 14 85
MULT 7 0 0 4 49 4 24
OTHER 204 3 157 19 231 37 225
PEOLC 50 0 0 5 61 11 67
PREV 304 4 209 18 219 27 164
SURV 6 0 0 2 24 3 18
SXQOL 422 4 209 23 280 50 304
Total 4007 47 2453 313 3810 613 3731

07-AUG-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 749 15 783 75 913 155 944
ERLYTX 80 0 0 8 97 14 85
GI 108 1 52 6 73 19 116
GU 238 1 52 19 231 42 256
LEUK 81 4 209 7 85 19 116
LUNG 364 3 157 12 146 20 122
LYMPH 257 4 209 24 292 43 262
MMYEL 238 1 52 10 122 16 97
MULT 5 0 0 0 0 2 12
Total 2120 29 1514 161 1959 330 2010

07-AUG-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1980 25 1304 170 2070 330 2009
AFFIL 163 1 52 9 110 18 110
CCOP/NCORP 1458 17 887 101 1230 199 1211
Non-SWOG 1785 26 1357 135 1644 275 1674
Total 5386 69 3600 415 5054 822 5004

07-AUG-2025 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 Y 04-AUG-25

07-AUG-2025 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU EA8212 Blad, NMIBC, BRIDGE 1 E 24-JUL-25
GU A031803 Blad, NMIBC, Gemcitabine + MK-3475 1 E 23-JUL-25
GI A022104 Rectal, Loc Adv, Triplet vs Doublet Chemo 1 E 21-JUL-25
BREAST NRGBR008 Breast, LowRisk HER2+, Radiotherapy 1 E 04-AUG-25

07-AUG-2025 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 16
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 12
MELAN S2015 MELAN, Stg I-II, 1cm v 2cm excision margins 1 6
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 5
PREV A212102 Blind Ref Set for Multicancer Early Detection 1 4
LEUK MM1YA-S01 AML, High Risk, Age <60, 7+3 vs experimental 1 4
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 4
GU A032103 Urothelial, All Stg, MRD-Based Adj Tx 0 3
LYMPH AHOD2131 cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy 2 3
LUNG LUNGMAP NSCLC, Adv, Master 2 3
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 2 3
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3